The historical rank and industry rank for TransMedics Group's Pretax Margin % or its related term are showing as below:
TMDX'
s Pretax Margin % Range Over the Past 10 Years
Min: -387.58 Med: -126.98 Max: 17.76
Current: 14.05
TMDX's Pretax Margin % is ranked better than 77.14% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.505
vs TMDX: 14.05
TransMedics Group (NAS:TMDX) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
TransMedics Group Pretax Margin % Related Terms
TransMedics Group Pretax Margin % Historical Data
* Premium members only.
The historical data trend for TransMedics Group's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TMDX vs AXGN, ESTA, NVCR: Pretax Margin % Comparison
For the Medical Devices subindustry, TransMedics Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TransMedics Group Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where TransMedics Group's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TransMedics Group (TMDX) has a Pretax Margin % of 4.88% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on TransMedics Group and its competitors. According to the industry distribution chart, TransMedics Group ranks #187 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 22.9%.
Is TransMedics Group's Pretax Margin % too high?
TransMedics Group's current Pretax Margin % is 4.88%. The Medical Devices & Instruments industry median Pretax Margin % is 2.51. TransMedics Group's value of 4.88% is 94.8% above this industry median. Based on the distribution chart, TransMedics Group ranks #187 out of 818 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, TransMedics Group has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TransMedics Group's Pretax Margin % compare to AXGN and ESTA?
According to the Medical Devices & Instruments industry distribution chart, TransMedics Group ranks #187 out of 818 companies for Pretax Margin %. This places TransMedics Group in the top 23% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.51. TransMedics Group's value of 4.88% is 94.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TransMedics Group's current Pretax Margin % of 4.88% is 94.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on TransMedics Group and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TransMedics Group's current Pretax Margin % is 4.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransMedics Group stock overvalued right now?
Based on GuruFocus' analysis, TransMedics Group (TMDX) is currently considered Possible Value Trap. The stock's GF Value™ is $166.36, compared to a current price of $68.44 — trading 58.9% below its estimated fair value. The current Pretax Margin % is 4.88% and 94.8% above the Medical Devices & Instruments industry median of 2.51. TransMedics Group's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For TransMedics Group (TMDX), the current Pretax Margin % is 4.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TransMedics Group (TMDX) Overvalued in 2026?
Based on GuruFocus' analysis, TransMedics Group stock appears to be undervalued.
The current stock price of $68.44 is trading 58.9% below its estimated GF Value™ of $166.36.
GuruFocus considers TransMedics Group to be Possible Value Trap.
Key valuation signals for TMDX:
Pretax Margin %: 4.88%
GF Value™: $166.36 vs. price of $68.44 (58.9% below fair value)
Industry Position: 94.8% above the Medical Devices & Instruments median (#187 of 818)
No single metric tells the full story. See the TMDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
69GF Score
Get the complete analysis for TMDX
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TMDX has been successfully added to your 
